US Edition
Published • loading... • Updated
Neuspera Medical Announces 12-Month Pivotal Trial Results for the Company's Integrated Sacral Neuromodulation System for Urinary Urge Incontinence
Summary by The Chandler Arizonan
6 Articles
6 Articles
The Chandler Arizonan+4 Reposted by 4 other sources
Neuspera Medical Announces 12-Month Pivotal Trial Results for the Company's Integrated Sacral Neuromodulation System for Urinary Urge Incontinence
94% of Test-Phase Responders Achieved Significant Symptom Relief with Zero Serious Device-Related Adverse EventsNew Data Suggests 30 Minutes of Daily iSNM Therapy Provides UUI Symptom Relief
·Chandler, United States
Read Full Article
Neuspera reports positive data in urinary urge incontinence device trial
Neuspera Medical has reported encouraging 12-month pivotal trial results for its iSNM, Neuspera SNM, in patients with UUI.The post Neuspera reports positive data in urinary urge incontinence device trial appeared first on Medical Device Network.
Coverage Details
Total News Sources6
Leaning Left1Leaning Right0Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 33%
C 67%
Factuality
To view factuality data please Upgrade to Premium
